ICU Medical, Inc.
ICUI
Market Cap$3.32B
Close$
$284.34
113.9% upside
Current Fair Value
113.9% upsideUndervalued by 113.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.32 Billion |
|---|---|
| Enterprise Value | $4.77 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.83 |
| Beta | 0.88 |
| Outstanding Shares | 24,539,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -35.32 |
|---|---|
| PEG | 58.1 |
| Price to Sales | 1.36 |
| Price to Book Ratio | 1.64 |
| Enterprise Value to Revenue | 1.97 |
| Enterprise Value to EBIT | 60.87 |
| Enterprise Value to Net Income | -51 |
| Total Debt to Enterprise | 0.36 |
| Debt to Equity | 0.88 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About ICU Medical, Inc.
9,000 employees
CEO: Vivek Jain ICU Medical, Inc. is a San Clemente, California-based company with global operations that develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical’s products a...